HOUSTON--(BUSINESS WIRE)--CytoGenix, Inc. (OTCBB:CYGX) announced today delivery of the first of a series of three sequences of synDNA™. This delivery was a reorder of synDNA™ with Quality Control specifications meeting the customer’s request for scale and purity.
